Select for export Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/17460441.2022.2111415 PubMed 35934973 Copy citation Copy BibTeX Expert Opinion on Drug Discovery 2022-08-21 Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. Europe PMC Published psilocybin DepressionPharmacologyMechanism of Action Animal Study More
Select for export The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/07067437221111371 PubMed 35975555 Copy citation Copy BibTeX Unknown journal 2022-08-16 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01361-0 PubMed 35953638 Copy citation Copy BibTeX Unknown journal 2022-08-11 Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. Europe PMC Published psilocybin DepressionEnd-of-Life DistressMechanism of Action Clinical Trial More
Select for export Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/jpm.2022.0036 PubMed 35285721 Copy citation Copy BibTeX Journal of palliative medicine 2022-07-31 Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K PubMed Published psilocybin DepressionAnxietyPTSD Other More
Select for export Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-07-24 University of California, San Diego ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psychedelics in the treatment of unipolar and bipolar depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40345-022-00265-5 PubMed 35788817 Copy citation Copy BibTeX Unknown journal 2022-07-04 Bosch OG, Halm S, Seifritz E. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Brain dynamics predictive of response to psilocybin for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.06.30.497950 Copy citation Copy BibTeX bioRxiv 2022-07-03 Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ bioRxiv PREPRINT (not peer reviewed) psilocybinpsilocin DepressionMechanism of ActionReceptor Pharmacology Other More
Select for export Psychedelic use in India, its pattern and personal significance - findings from an online survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4103/indianjpsychiatry.indianjpsychiatry_447_21 PubMed 36060724 Copy citation Copy BibTeX Indian Journal of Psychiatry 2022-06-30 Gokul Raj OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Self-administration of Psilocybin in the Setting of Treatment-resistant Depression. Abstract available at the source but not redistributed here. Read at source. Details PubMed 36204170 Copy citation Copy BibTeX PubMed 2022-06-30 Lyons A. Europe PMC Published psilocybin DepressionMicrodosingRandomized Controlled Trial Clinical Trial More
Select for export How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06106-8 PubMed 35348806 Copy citation Copy BibTeX Psychopharmacology 2022-05-31 van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH PubMed Published psilocybin DepressionPharmacologyMystical Experience Other More
Select for export Unraveling the Mysteries of Mental Illness With Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.25414 PubMed 35769681 Copy citation Copy BibTeX Unknown journal 2022-05-26 Sotille R, Singh H, Weisman A, Vida T. Europe PMC Published psilocybinpsilocin DepressionNeuroplasticityReceptor Pharmacology Clinical Trial More
Select for export Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-05-19 National Institute of Mental Health, Czech Republic ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export Magic mushroom extracts in lipid membranes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.bbamem.2022.183957 PubMed 35561790 Copy citation Copy BibTeX Biochimica et Biophysica Acta (BBA) - Biomembranes 2022-05-09 Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H. Europe PMC Published psilocybinpsilocin DepressionAddictionReceptor Pharmacology Other More
Select for export Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-04-28 University of Zurich ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2022.02.624 Copy citation Copy BibTeX Biological Psychiatry 2022-04-27 Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes OpenAlex Published psilocybin DepressionAnxietyClinical Trial Randomized Controlled Trial More
Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674221083868 PubMed 35285280 Copy citation Copy BibTeX Unknown journal 2022-03-11 Kisely S, Connor M, Somogyi AA, Siskind D. Europe PMC Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nsa.2022.100104 PubMed 40656230 Copy citation Copy BibTeX Neuroscience Applied 2022-03-06 Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A Europe PMC Published psilocybin DepressionClinical TrialSafety Clinical Trial More
Select for export Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyg.2022.813746 PubMed 35310225 Copy citation Copy BibTeX Unknown journal 2022-03-03 Sekula AD, Downey L, Puspanathan P. Europe PMC Published psilocybin DepressionAnxietyPTSD Other More
